Lab-on-a-chip explained

Reference guide written and published by biochip.com. Draft, not yet independently reviewed; last substantive update September 7, 2026.

A lab-on-a-chip (LOC) is a device, usually a few square centimetres, that performs several steps of a laboratory analysis in one integrated unit: taking in a sample, preparing it, running a reaction or separation, and detecting the result. The term is used more or less interchangeably with micro total analysis system (µTAS), the name under which the idea was first proposed. Lab-on-a-chip devices are built with microfluidics, but the phrase emphasises integration and purpose rather than fluid physics: the point is to replace a workflow, not just to shrink a channel.

Where the idea came from

The earliest recognised lab-on-a-chip was a gas chromatograph etched into a silicon wafer at Stanford in 1979, complete with an injection valve, a 1.5-metre spiral column and a detector (Terry, Jerman and Angell, IEEE Trans. Electron Devices 1979). It was a decade ahead of its time and found little use. The concept was reframed in 1990 by Andreas Manz and colleagues at Ciba-Geigy, who argued that shrinking a complete chemical analysis system would improve speed and performance, not merely size, because separation efficiency and reaction times scale favourably with dimension (Manz, Graber and Widmer, 1990). Chip-based capillary electrophoresis in the 1990s proved the point, and the Human Genome Project's demand for faster, cheaper analysis pulled the field forward.

What a lab-on-a-chip integrates

1. Sample introduction: a finger-prick of blood, a swab eluate, saliva or a water sample enters through a port or is wicked in by capillary action.
2. Sample preparation: filtering cells from plasma, lysing cells to release DNA, concentrating a target, or diluting and mixing with reagents. This is consistently the hardest part to miniaturise.
3. Reaction or separation: PCR or isothermal amplification of nucleic acids, immunoassay binding steps, enzymatic reactions, electrophoretic separation.
4. Detection: fluorescence, colour change, electrochemical current, surface plasmon resonance, or simple visual readout of a line.
5. Waste and containment: reagents and sample stay sealed inside a disposable cartridge, which matters for infectious samples.

Reagents are often stored on the chip, dried or in blister packs, so that the user adds only the sample. The cartridge is then read by an instrument that supplies pressure, heat and optics. That division of labour, cheap disposable chip plus reusable reader, is the dominant commercial pattern.

Where lab-on-a-chip devices are used today

Molecular diagnostics. Cartridge-based systems run PCR for tuberculosis, respiratory viruses, sexually transmitted infections and hospital-acquired pathogens in under an hour, at the clinic rather than the reference lab. Blood chemistry. Handheld analysers measure electrolytes, blood gases and cardiac markers from a few drops of blood at the bedside. Genomics. Microfluidic chips prepare sequencing libraries, partition single cells into droplets and run digital PCR. Global health. Yager and colleagues set out in 2006 how microfluidic diagnostics could work in settings with no electricity, refrigeration or trained staff (Yager et al., Nature 2006); five years later Chin and colleagues demonstrated a credit-card-sized immunoassay chip diagnosing HIV and syphilis in Rwanda with performance comparable to laboratory tests (Chin et al., Nature Medicine 2011).

Why so few academic devices reach the clinic

Thousands of lab-on-a-chip papers are published each year, and a small fraction become products. The usual reasons are not scientific. Sample-to-answer integration is much harder than demonstrating one step. Manufacturing requires switching from the elastomer PDMS, used in most academic work, to moulded plastics, which behave differently and need new designs. Reagent stability on the chip over months of shelf life is rarely addressed in research. Regulatory validation requires clinical studies whose cost dwarfs the device development. And the business case must beat an incumbent: central laboratories are efficient, and a point-of-care test must justify a higher per-test cost with a benefit such as faster treatment. Sackmann, Fulton and Beebe discuss these barriers and the cultural gap between engineers who build chips and biologists who would use them (Sackmann et al., Nature 2014).

How to read a lab-on-a-chip paper critically

• Was the sample real (whole blood, sputum) or a purified target spiked into buffer? Buffer results rarely survive contact with real samples.
• Is the whole workflow on the chip, or were preparation steps done off-chip by hand?
• How many samples were tested, and was performance compared against a reference method?
• What instrument does the chip need? A "handheld" chip that requires a benchtop microscope is not handheld.
• What material is it made of, and has anything been said about manufacturing?

Related terms

• µTAS (micro total analysis system): the original name for the concept; still used in the field's main conference.
• Point-of-care testing: diagnostic testing at or near the patient. Many, not all, point-of-care tests are lab-on-a-chip devices.
• Cartridge: the disposable chip plus its housing and stored reagents.
• Sample-to-answer: a system that needs no manual steps between adding the sample and reading the result.
• Biochip: the broader umbrella term; see what is a biochip?